Bioremediation is an established technology for removing PAHs from contaminated soil, but previous studies have shown that it does not always lead to a reduction in toxicity. The causes of toxicity and the mechanisms by which toxicity might be avoided or diminished are not well-understood. We hypothesize that metabolites produced by PAH-degrading bacteria, which have been observed to accumulate in field-contaminated soil and sediment, are responsible at least in part for the toxicity that can result from bioremediation. We also hypothesize that bioremediation conditions influence the community of PAH-degrading microorganisms in contaminated soil, which in turn influences both PAH removal and the extent to which metabolites might accumulate. We propose to explore the effects of bioremediation conditions on PAH removal and soil toxicity, using a slurry-phase bioreactor as the experimental platform. Among the conditions we will evaluate is the addition of a hydrophobic surfactant at a low dose, which we recently demonstrated can improve the bioavailability and biodegradation of PAHs that remained in a field-contaminated soil after conventional bioremediation. This approach will be developed further by demonstrating its efficacy in a semi-continuous process. We will combine our recent work on stable-isotope probing with a high-throughput DNA sequencing method to identify the PAH-degrading bacteria most likely to influence PAH removal, metabolite accumulation, and toxicity in the treated soil. Genomes of these organisms will be sequenced to identify genes associated with PAH metabolism, and the key genes will be expressed. Differences in the ability to metabolize various PAHs will be correlated to sequence differences in these genes so that genetic determinants of metabolite accumulation can be identified. In parallel, we will use fractionation techniques and advanced analytical tools to identify compounds responsible for toxicity of the treated soil. Finally, variables that can be controlled during bioremediation will be evaluated for their ability to preclude or mitigate toxicity. Our overall goal is to fill key gaps in knowledge that will inform and improve field applications of bioremediation that lead to true reductions in risk.

Public Health Relevance

This project is relevant to public health because it will broaden our understanding of risk reduction via bioremediation and will develop approaches to reducing risks. It is relevant to Superfund because it focuses on remediation of soil contaminated with PAHs, which are among the contaminants of most concern at Superfund sites.

National Institute of Health (NIH)
National Institute of Environmental Health Sciences (NIEHS)
Hazardous Substances Basic Research Grants Program (NIEHS) (P42)
Project #
Application #
Study Section
Special Emphasis Panel (ZES1-LWJ-V (05))
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Carolina Chapel Hill
Chapel Hill
United States
Zip Code
Martin, Elizabeth M; St├Żblo, Miroslav; Fry, Rebecca C (2017) Genetic and epigenetic mechanisms underlying arsenic-associated diabetes mellitus: a perspective of the current evidence. Epigenomics 9:701-710
Luo, Yu-Syuan; Cichocki, Joseph A; McDonald, Thomas J et al. (2017) Simultaneous detection of the tetrachloroethylene metabolites S-(1,2,2-trichlorovinyl) glutathione, S-(1,2,2-trichlorovinyl)-L-cysteine, and N-acetyl-S-(1,2,2-trichlorovinyl)-L-cysteine in multiple mouse tissues via ultra-high performance liquid chromatog J Toxicol Environ Health A 80:513-524
Grimm, Fabian A; Russell, William K; Luo, Yu-Syuan et al. (2017) Grouping of Petroleum Substances as Example UVCBs by Ion Mobility-Mass Spectrometry to Enable Chemical Composition-Based Read-Across. Environ Sci Technol 51:7197-7207
Smeester, Lisa; Bommarito, Paige A; Martin, Elizabeth M et al. (2017) Chronic early childhood exposure to arsenic is associated with a TNF-mediated proteomic signaling response. Environ Toxicol Pharmacol 52:183-187
McEachran, Andrew D; Shea, Damian; Nichols, Elizabeth Guthrie (2017) Pharmaceuticals in a temperate forest-water reuse system. Sci Total Environ 581-582:705-714
Huang, Madelyn C; Douillet, Christelle; Su, Mingming et al. (2017) Metabolomic profiles of arsenic (+3 oxidation state) methyltransferase knockout mice: effect of sex and arsenic exposure. Arch Toxicol 91:189-202
Zhou, Yi-Hui; Cichocki, Joseph A; Soldatow, Valerie Y et al. (2017) Editor's Highlight: Comparative Dose-Response Analysis of Liver and Kidney Transcriptomic Effects of Trichloroethylene and Tetrachloroethylene in B6C3F1 Mouse. Toxicol Sci 160:95-110
Gao, Lina; Mutlu, Esra; Collins, Leonard B et al. (2017) DNA Product Formation in Female Sprague-Dawley Rats Following Polyhalogenated Aromatic Hydrocarbon (PHAH) Exposure. Chem Res Toxicol 30:794-803
Nakamura, Jun; Shimomoto, Takasumi; Collins, Leonard B et al. (2017) Evidence that endogenous formaldehyde produces immunogenic and atherogenic adduct epitopes. Sci Rep 7:10787
Brooks, Samira A; Fry, Rebecca C (2017) Cadmium inhibits placental trophoblast cell migration via miRNA regulation of the transforming growth factor beta (TGF-?) pathway. Food Chem Toxicol 109:721-726

Showing the most recent 10 out of 483 publications